Releases › ICD-10-PCS FY2027
ICD-10-PCS FY2027
Effective 2026-10-01 to 2027-09-30. 79,256 codes in the release.
103added
3revised
39removed
Codes added 103
| Code | Description |
|---|---|
| 028F3Z0 | Division of Aortic Valve, Percutaneous Approach, Native Leaflet |
| 028F3Z1 | Division of Aortic Valve, Percutaneous Approach, Prosthetic Leaflet |
| 028G3Z0 | Division of Mitral Valve, Percutaneous Approach, Native Leaflet |
| 028G3Z1 | Division of Mitral Valve, Percutaneous Approach, Prosthetic Leaflet |
| 0RGA0E0 | Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach |
| 0RGA0EJ | Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach |
| 0RGA3E0 | Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach |
| 0RGA3EJ | Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach |
| 0RGA4E0 | Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0RGA4EJ | Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0SG00E0 | Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach |
| 0SG00EJ | Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach |
| 0SG03E0 | Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach |
| 0SG03EJ | Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach |
| 0SG04E0 | Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0SG04EJ | Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0SG10E0 | Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach |
| 0SG10EJ | Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach |
| 0SG13E0 | Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach |
| 0SG13EJ | Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach |
| 0SG14E0 | Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0SG14EJ | Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0SG30E0 | Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach |
| 0SG30EJ | Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach |
| 0SG33E0 | Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach |
| 0SG33EJ | Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach |
| 0SG34E0 | Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0SG34EJ | Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach |
| 0W99003 | Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Open Approach |
| 0W99303 | Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Approach |
| 0W99403 | Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach |
| 0W9B003 | Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Open Approach |
| 0W9B303 | Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Approach |
| 0W9B403 | Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach |
| 0W9C003 | Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Open Approach |
| 0W9C303 | Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Percutaneous Approach |
| 0W9C403 | Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach |
| 30233S5 | Transfusion of High-Dose Immune Globulin into Peripheral Vein, Percutaneous Approach |
| 30243S5 | Transfusion of High-Dose Immune Globulin into Central Vein, Percutaneous Approach |
| 3E00XGF | Introduction of Other Enzymatic/Chemical Agent into Skin and Mucous Membranes, External Approach |
| 3E01XGF | Introduction of Other Enzymatic/Chemical Agent into Subcutaneous Tissue, External Approach |
| 5A0527D | Assistance with Circulatory Decompression using Impeller Pump, Continuous |
| 5A1D701 | Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day, Selective Cytopheresis |
| 5A1D801 | Performance of Urinary Filtration, Prolonged Intermittent, 6-18 hours Per Day, Selective Cytopheresis |
| 5A1D901 | Performance of Urinary Filtration, Continuous, Greater than 18 hours Per Day, Selective Cytopheresis |
| B85 | Imaging, Eye, Other Imaging |
| B85A2ZZ | Other Imaging of Right Choroid using Fluorescing Agent |
| B85B2ZZ | Other Imaging of Left Choroid using Fluorescing Agent |
| B85G2ZZ | Other Imaging of Right Retinal Vessel using Fluorescing Agent |
| B85H2ZZ | Other Imaging of Left Retinal Vessel using Fluorescing Agent |
| X0HQ05C | Insertion of Leadless Neurostimulator Generator into Vagus Nerve, Open Approach, New Technology Group 12 |
| X27P3NC | Dilation of Right Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 |
| X27Q3NC | Dilation of Left Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 |
| X27R3NC | Dilation of Right Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 |
| X27S3NC | Dilation of Left Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 |
| X27T3NC | Dilation of Right Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 |
| X27U3NC | Dilation of Left Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12 |
| X28M3DC | Division of Ventricular Septum using Transcatheter Septal Scoring Technique, Percutaneous Approach, New Technology Group 12 |
| X2H43MC | Insertion of Temporary Intraluminal Device, Venous Angle Decompression using Impeller Pump into Left Innominate Vein, Percutaneous Approach, New Technology Group 12 |
| X2RF3LC | Replacement of Aortic Valve using Zooplastic Tissue, with Integrated Native Leaflet Clipping Locators, Percutaneous Approach, New Technology Group 12 |
| X2RG3FC | Replacement of Mitral Valve with Balloon-expandable Bioprosthetic Valve with Dock, Percutaneous Approach, New Technology Group 12 |
| X2RH0GC | Replacement of Pulmonary Valve using Size-Adjustable Synthetic Substitute, Open Approach, New Technology Group 12 |
| X2VJ3HC | Restriction of Thoracic Aorta, Ascending and Arch using Branched Intraluminal Device, Integrated System with Innominate Branch, Percutaneous Approach, New Technology Group 12 |
| X2VW3JC | Restriction of Thoracic Aorta, Descending using Branched Intraluminal Device, Integrated System Extension, Percutaneous Approach, New Technology Group 12 |
| X2VX0KC | Restriction of Thoracic Aorta, Arch using Branched Intraluminal Device, with Conical Collar, Open Approach, New Technology Group 12 |
| XEZ | New Technology, Physiological Systems and Anatomical Regions |
| XEZ5XKC | Computer-Aided Triage and Notification for Imaging Abnormalities in Computed Tomography of Chest, Abdomen and Pelvis, New Technology Group 12 |
| XEZD3QC | Pericardial Cavity Access using Blunt-tip Concealed Needle with Mechanical Gripping Mechanism, Percutaneous Approach, New Technology Group 12 |
| XEZJ3NC | Coronary Artery Access using Image-Guided Crossing and Re-entry System, Percutaneous Approach, New Technology Group 12 |
| XEZU3HC | Computer-Aided Guidance for Intraprocedural Navigation using Ultrasound Imaging with Continuous Needle Tracking in Spinal Canal, Percutaneous Approach, New Technology Group 12 |
| XEZZXJC | High Dimensional Mixture-of-Experts Computer-aided Assessment of Inflammatory Response and Organ Function, for Notification and Triage, New Technology Group 12 |
| XEZZXLC | Computer-Aided Detection and Notification for Imaging Abnormalities in Echocardiography, New Technology Group 12 |
| XEZZXMC | Computer-Aided Detection and Notification for Abnormalities in Electrocardiogram, New Technology Group 12 |
| XEZZXPC | Cardiac Conduction Mechanism, Computer-aided Guidance for Three Dimensional Intraprocedural Navigation using Fluoroscopic Imaging, New Technology Group 12 |
| XEZZXRC | Computer-Aided Detection and Notification of Cardiac Abnormalities using Vital Signs, New Technology Group 12 |
| XEZZXSC | Cardiac Conduction Mechanism, Computer-aided Intraprocedural Visualization for Guidance, New Technology Group 12 |
| XFJB3CC | Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12 |
| XFJB4CC | Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12 |
| XFJB8BC | Inspection of Hepatobiliary Duct using Single-use Cholangioscope, Via Natural or Artificial Opening Endoscopic Approach, New Technology Group 12 |
| XFJD3CC | Inspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12 |
| XFJD4CC | Inspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12 |
| XFJD8BC | Inspection of Pancreatic Duct using Single-use Cholangioscope, Via Natural or Artificial Opening Endoscopic Approach, New Technology Group 12 |
| XHH80JC | Insertion of Contractility Modulation Device with Defibrillator Generator into Chest Subcutaneous Tissue and Fascia, Open Approach, New Technology Group 12 |
| XRH10NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Open Approach, New Technology Group 12 |
| XRH13NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Approach, New Technology Group 12 |
| XRH14NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12 |
| XRH20NC | Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Open Approach, New Technology Group 12 |
| XRH23NC | Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Approach, New Technology Group 12 |
| XRH24NC | Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 12 |
| XRH40NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Open Approach, New Technology Group 12 |
| XRH43NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Approach, New Technology Group 12 |
| XRH44NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12 |
| XRH60NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 12 |
| XRH63NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 12 |
| XRH64NC | Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12 |
| XW0134C | Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12 |
| XW0336C | Introduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12 |
| XW0337C | Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12 |
| XW0436C | Introduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12 |
| XW0Q35C | Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12 |
| XW0U0CC | Introduction of Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold into Joints, Open Approach, New Technology Group 12 |
| XW0V0BC | Introduction of Vancomycin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 12 |
| XXE2XHC | Measurement of Cardiac Conduction Mechanism, Computer-aided Mapping for Planning, New Technology Group 12 |
Descriptions revised 3
| Code | Was, and is now |
|---|---|
| XW0E33B | |
| XW0V0P7 | |
| XW143F8 |
Codes removed 39
| Code | Description |
|---|---|
| X2KB317 | Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 |
| X2KC317 | Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 |
| XD2 | New Technology, Gastrointestinal System, Monitoring |
| XD2G4V7 | Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XD2G8V7 | Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 |
| XD2H4V7 | Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XD2H8V7 | Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 |
| XRGA0R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGA3R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGA4R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XRGB0R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGB3R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGB4R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XRGC0R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGC3R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGC4R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XRGD0R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 |
| XRGD3R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 |
| XRGD4R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 |
| XW00X27 | Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7 |
| XW01397 | Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 |
| XW01X27 | Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7 |
| XW023X7 | Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 |
| XW03367 | Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW03377 | Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW03387 | Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW033B7 | Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW04367 | Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW04377 | Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW04387 | Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW043B7 | Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XW0DXR7 | Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7 |
| XW0G7R7 | Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7 |
| XW0H7R7 | Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7 |
| XW133D7 | Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
| XW133F8 | Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
| XW143D7 | Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7 |
| XXE5XR7 | Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7 |
| XXE5XT7 | Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7 |